How do MDS genetic mutations influence decisions for stem cell transplant?

Expert Video - How do MDS genetic mutations influence decisions for stem cell transplant?

MDS expert Rafael Bejar, MD, PhD, shares how the type of genetic mutation present in MDS can make an allogeneic stem cell transplant, or bone marrow transplant, more desirable – for example, in high-risk myelodysplastic syndromes (MDS). Knowing which genetic mutations are present can also help doctors and patients decide if alternatives such as experimental therapies or myelodysplastic syndromes (MDS) are better options if the mutation makes relapse more likely.

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.

Please rate this content:

Other Modules:

Understanding Myelodysplastic Syndromes

Understanding MDS-related Anemia

Understanding Erythropoiesis

Diagnosis of MDS

Understanding Genetic Mutations in MDS

Management and Treatment of MDS

Managing and Treating MDS-related Anemia

Mutation-Driven Therapy in MDS

Blood and Marrow Transplantation in MDS

Animation - Mutation-Driven Therapy in MDS

Slide Show - Mutation-Driven Therapy in MDS

Expert Videos

1. How does my genetic mutation profile impact the treatment of my MDS?

2. What are mutation-driven MDS treatments?

3. What are the goals of mutation-driven MDS treatments?

4. How does my MDS genetic mutation permit personalized treatment decisions?

5. What questions should I ask my doctor about mutation-driven MDS treatments?